Earnings Preview

MELE.BR Melexis NV Earnings Preview April 29, 2026

April 28, 2026
6 min read

Key Points

Analysts expect $0.61 EPS and $202.35M revenue on April 29

Recent earnings declined 34% YoY with margin compression across profitability metrics

Premium 25.58 P/E valuation leaves limited room for earnings disappointment

Strong balance sheet and 21.4% ROE support recovery potential if automotive demand stabilizes

Melexis NV (MELE.BR) reports earnings on April 29, 2026, with analysts expecting $0.61 EPS and $202.35M revenue. The Belgian semiconductor company designs advanced sensor chips for automotive applications across Europe, Asia, and the Americas. Trading at €71.10 with a €2.81B market cap, Melexis faces investor scrutiny as the semiconductor sector navigates supply chain recovery and automotive demand shifts. Recent financial data shows mixed signals: the company posted a 25.58 P/E ratio and 5.9x price-to-book, suggesting premium valuation. This earnings preview examines what to expect, key metrics to monitor, and whether management can deliver on consensus estimates.

Earnings Estimates and What They Mean

Analysts project Melexis will deliver $0.61 earnings per share and $202.35M in quarterly revenue. These estimates reflect cautious optimism about automotive semiconductor demand recovery. The revenue target represents a critical test for the company’s ability to maintain market share amid competitive pressures.

EPS Estimate Analysis

The $0.61 EPS forecast compares against trailing twelve-month earnings of $2.78 per share. This suggests a significant quarterly decline, typical for semiconductor cyclicality. Investors should note the company’s net profit margin of 13.4%, which provides some cushion if revenue misses slightly. The estimate assumes stable operating costs and no major one-time charges.

Revenue Target Breakdown

The $202.35M revenue estimate reflects steady demand from automotive customers. Melexis generates revenue from magnetic position sensors, current sensors, temperature sensors, and motor driver ICs. The company’s price-to-sales ratio of 3.35x indicates the market prices in moderate growth expectations. Any revenue beat above $205M would signal stronger automotive production than anticipated.

Melexis faces headwinds from recent financial deterioration. Year-over-year metrics show concerning declines across profitability measures, though long-term trends remain positive. Understanding these dynamics helps predict earnings surprises.

Recent Profitability Decline

Full-year 2025 results revealed net income fell 34.4% and EPS dropped 34% compared to 2024. Operating income declined 39.1%, indicating margin compression beyond just revenue softness. However, the company maintains strong cash generation with €3.14 operating cash flow per share. This suggests operational challenges rather than fundamental business deterioration.

Gross Margin and Operating Efficiency

Gross profit margins contracted 19.3% year-over-year, reflecting higher manufacturing costs and unfavorable product mix. Operating margins fell to 16% from prior levels. The company’s R&D spending at 13.8% of revenue remains elevated, supporting long-term competitiveness. Management must demonstrate cost discipline while maintaining innovation investments to restore investor confidence.

Key Metrics and Valuation Signals

Melexis trades at premium valuations despite recent earnings pressure. Current metrics reveal investor expectations for recovery and growth. These signals help frame realistic earnings outcomes.

Valuation Multiples and Market Expectations

The 25.58 P/E ratio sits above semiconductor sector averages, pricing in recovery assumptions. The 5.9x price-to-book ratio reflects confidence in asset quality and return on equity of 21.4%. However, the 3.35x price-to-sales multiple suggests the market expects margin improvement. Any earnings miss could trigger multiple compression given these elevated valuations.

Balance Sheet Strength and Cash Position

Melexis maintains a strong balance sheet with current ratio of 5.46x, indicating excellent liquidity. The company carries €287M in net debt against €2.81B market cap, a manageable 11.5% debt-to-market-cap ratio. Free cash flow of €2.39 per share supports the €3.70 dividend yield. This financial flexibility provides downside protection if earnings disappoint.

What Investors Should Watch During Earnings

The April 29 earnings call will reveal management guidance and operational updates critical for stock direction. Specific metrics deserve close attention to assess recovery momentum and competitive positioning.

Automotive Demand Signals and Customer Commentary

Management commentary on automotive production trends will be crucial. Melexis derives majority revenue from car manufacturers, making OEM demand visibility essential. Watch for guidance on electric vehicle sensor adoption, which drives higher content per vehicle. Any weakness in European or Asian automotive production could pressure 2026 guidance.

Margin Recovery Timeline and Cost Actions

Investors should listen for specific margin improvement initiatives. The 39% operating income decline demands explanation and remediation plans. Management must articulate whether margin pressure is temporary cyclical weakness or structural. Guidance on R&D spending levels and manufacturing efficiency improvements will signal confidence in recovery trajectory.

Cash Flow and Capital Allocation Plans

Free cash flow generation remains strong at €2.39 per share, but investors want clarity on capital deployment. Watch for updates on share buyback programs, dividend sustainability, and acquisition strategy. The company’s ability to maintain shareholder returns while investing in growth will influence stock performance post-earnings.

Final Thoughts

Melexis enters earnings season with solid fundamentals including strong cash flow and 21.4% ROE, but faces a critical test. The €71.10 stock price reflects a premium 25.58 P/E valuation with limited room for error. Key focus areas are automotive demand visibility and margin recovery timelines. Management guidance on 2026 earnings trajectory will determine whether the stock sustains current levels or faces correction. Meyka AI rates MELE.BR as B+, balancing solid fundamentals against cyclical headwinds and valuation concerns.

FAQs

What is the EPS estimate for Melexis earnings on April 29?

Analysts expect $0.61 earnings per share, down significantly from trailing twelve-month EPS of $2.78, reflecting semiconductor cyclicality and automotive sector profitability pressures.

How does the revenue estimate compare to historical performance?

The $202.35M revenue estimate reflects cautious demand expectations. Full-year 2025 revenue declined 10% year-over-year, indicating ongoing market softness and stabilization rather than recovery.

What should investors watch for during the earnings call?

Monitor automotive demand commentary, margin recovery plans, and 2026 guidance. Management must explain the 39% operating income decline and outline cost actions. EV sensor adoption and capital allocation guidance will influence stock direction.

Is Melexis overvalued at current price levels?

The 25.58 P/E ratio exceeds sector averages but appears justified by 21.4% ROE and strong balance sheet. Valuation is fair if management delivers margin improvement and automotive demand stabilizes.

What does the Meyka AI B+ grade mean for investors?

The B+ grade reflects solid fundamentals offset by cyclical headwinds, factoring in S&P 500 comparison and analyst consensus. It suggests neutral positioning with moderate upside on earnings beats.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)